© The Author(s) 2012. This article is published with open access at Springerlink.com Introduction: In the western hemisphere, age-related macular degeneration (AMD) is the leading cause of visual loss in the elderly. Currently approved therapies for AMD include argon laser, photodynamic therapy, an
Introduction: In developed countries, neovascular age-related macular degeneration (AMD) is the lead...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Copyright © 2013 Mostafa Hanout et al.This is an open access article distributed under theCreative C...
The treatment of exudative age-related macular degeneration (AMD) has been completely transformed by...
<p><b>Introduction</b>: Age related macular degeneration (AMD) affects over 14 million people worldw...
Aflibercept is a fully human recombinant fusion protein that includes the second domain of human VEG...
Copyright © 2015 Makoto Ishikawa et al. This is an open access article distributed under the Creativ...
Aflibercept is a fully human recombinant fusion protein that includes the second domain of human VEG...
Chandrakumar Balaratnasingam,1–3 Elona Dhrami-Gavazi,1,2,4 Jesse T McCann,1,2,4,5 Quraish Ghad...
PURPOSE: The recent introduction of anti-VEGF drugs has widely changed the prognosis of exudativ...
Purpose: Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an...
Stephanie M Kaiser, Sruthi Arepalli, Justis P Ehlers Cole Eye Institute, Cleveland Clinic, Cleveland...
Age-related macular degeneration(AMD)is one of the major reasons of blindness among the elderly in t...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Introduction: In developed countries, neovascular age-related macular degeneration (AMD) is the lead...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Copyright © 2013 Mostafa Hanout et al.This is an open access article distributed under theCreative C...
The treatment of exudative age-related macular degeneration (AMD) has been completely transformed by...
<p><b>Introduction</b>: Age related macular degeneration (AMD) affects over 14 million people worldw...
Aflibercept is a fully human recombinant fusion protein that includes the second domain of human VEG...
Copyright © 2015 Makoto Ishikawa et al. This is an open access article distributed under the Creativ...
Aflibercept is a fully human recombinant fusion protein that includes the second domain of human VEG...
Chandrakumar Balaratnasingam,1–3 Elona Dhrami-Gavazi,1,2,4 Jesse T McCann,1,2,4,5 Quraish Ghad...
PURPOSE: The recent introduction of anti-VEGF drugs has widely changed the prognosis of exudativ...
Purpose: Neovascular age-related macular degeneration (AMD) is a leading cause of blindness, with an...
Stephanie M Kaiser, Sruthi Arepalli, Justis P Ehlers Cole Eye Institute, Cleveland Clinic, Cleveland...
Age-related macular degeneration(AMD)is one of the major reasons of blindness among the elderly in t...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Introduction: In developed countries, neovascular age-related macular degeneration (AMD) is the lead...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Abstract BACKGROUND: Age-related macular degeneration (AMD) is a condition that accounts for 75% o...
Add to ORKG